Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

Can Healthy Lifestyle Improve Quality of Life in Psoriasis?

High levels of physical activity, adequate sleep, and a healthy BMI are linked to lower odds of quality-of-life impairments in patients with psoriasis.

Infrequent Primary Care Consulters Face Higher Cancer Risk

Patients who visit the doctor less often before their urgent suspected cancer referrals are more likely to receive a diagnosis of cancer than those who consult more frequently.

Cosmo Pharma's Male Hair Loss Treatment Shows Sustained Hair Growth in Year‑long Study

Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth ⁠and long-term safety in men with common pattern baldness after a...

IDEAYA and Servier's Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

Lung Test May Predict Transition From Early to Definite SSc

A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.

Oral JAK1 Inhibitor Povorcitinib Shows Promise in HS

Abscesses and nodules improve significantly at 12 and 54 weeks.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

High levels of physical activity, adequate sleep, and a healthy BMI are linked to lower odds of quality-of-life impairments in patients with psoriasis.

Patients who visit the doctor less often before their urgent suspected cancer referrals are more likely to receive a diagnosis of cancer than those who consult more frequently.

Cosmo Pharmaceuticals said on Wednesday its experimental hair loss treatment showed sustained hair growth ⁠and long-term safety in men with common pattern baldness after a...

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.

Abscesses and nodules improve significantly at 12 and 54 weeks.

News All Time

Strength Training Potentially Beneficial in Patients With HS

Development of validated interventions and guidance for physical therapists and dermatologists — and HS patients themselves — is a goal.

Indoor Tanning Linked to Melanoma Diagnosis at Younger Age

Exposure to indoor tanning, especially before age 25, is associated with substantially earlier melanoma diagnosis compared with no exposure.

Topical Probiotics Boost Diabetic Foot Ulcer Healing

Topical probiotics significantly improve healing rates and reduce time to heal in diabetic foot ulcers, compared with placebo, in a study.

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Superficial Radiation Tx Costs Exceed Mohs Surgery for NMSC

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

Research Uncovers Mental Health Toll of Alopecia on Women

Black women are at greater risk for depression and anxiety, and scarring forms are linked to more disorders.

ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in patients with skin of color vs lighter skin tones.

Consensus Defines Vitiligo Severity, Relapse Beyond BSA

An international consensus study establishes standardized definitions for vitiligo severity and relapse, emphasizing that body surface area alone is insufficient to capture disease burden.

First-Line Biologics May Improve Psoriasis Outcomes

Biologics as a first-line systemic therapy are associated with better clinical outcomes and lower risks for chronic comorbidities in patients with moderate-to-severe psoriasis.

Recommended News For You

Improved end-of-life conversations for cancer patients are identified by a new study.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Study identifies new target for obesity-related breast cancer

Study reveals increase in late-stage breast cancer diagnoses in US

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

How cancer misinformation exploits the way we think

A Chemo-Free Option for Some Advanced Endometrial Cancers?

Recommended Articles For You

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia 

Navigating the Unknown: How to Cope with Anaplastic Thyroid Cancer 

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer 

Vaccines that can help prevent cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study reveals increase in late-stage breast cancer diagnoses in US

2.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

5.

An individual state lost $4.02 billion due to untreated mental illness.

1.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

2.

The Importance of Balanced Potassium Levels in Maintaining Good Health

3.

Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer

4.

Exploring the Latest Treatments for Essential Thrombocythemia

5.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap

2.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

5.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot